|Year : 2017 | Volume
| Issue : 3 | Page : 502-508
Acute coronary syndrome-related mortality audit in a teaching hospital at Port Blair, India
Shiv Shankar Singh1, Swapan Kumar Paul2, Ranabir Pal2, Pandurang Vithal Thatkar2
1 Department of Medicine, Andaman and Nicobar Islands Institute of Medical Sciences, Port Blair, Andaman and Nicobar Islands
2 Department of Community Medicine, Andaman and Nicobar Islands Institute of Medical Sciences, Port Blair, Andaman and Nicobar Islands
|Date of Web Publication||29-Dec-2017|
Dr. Swapan Kumar Paul
Department of Community Medicine, Andaman and Nicobar Islands Institute of Medical Sciences, Port Blair, Andaman and Nicobar Islands
Source of Support: None, Conflict of Interest: None
Background: India has a growing trend of acute myocardial infarction (AMI) due to shifting lifestyle. Objective: To study the profile of patients died due to AMI and to find its risk correlates. Methods: A study was conducted on consecutive AMI cases admitted in the teaching hospital at Port Blair from April 2011 to March 2016. During inpatients management, outcomes were followed up from admission till discharge or expiry. Results: Of the total 491 cases, majority (75.99%) had ST-elevated myocardial infarction (STEMI); mean age of 73 deaths was 58.01 ± 13.60, mortality probability among females was less; in the age group 41–50 years the case fatality rate was the lowest (7.58%). Mean age of survival was 56.75 ± 10.47; great majorities were males across all age groups in cases and deaths; highest number of cases were in the age group 51–60 (34.21%); reportedly 83.10% had some physical activities; 6.52% were vegetarian; 34.22% were smokers; 10.39% had family history of AMI, majority (59.06%) were from white collar profession (teacher, clerical, etc.); 52.95% were diabetics; and 47.45% were hypertensives. Lifestyle-related risk factors, physical activity, and vegetarian diet were not protective; family history and addiction to smoking were significantly associated with AMI deaths. Thrombolytic intervention helped the survival of 73.68%, and the odds ratio of survival showed benefit. Conclusions: Acute STEMI had male and middle-age predominance with a common risk factor of family history, smoking, diabetes, and hypertension.
Keywords: Acute myocardial infarction, coronary artery disease, ST-elevated myocardial infarction
|How to cite this article:|
Singh SS, Paul SK, Pal R, Thatkar PV. Acute coronary syndrome-related mortality audit in a teaching hospital at Port Blair, India. J Family Med Prim Care 2017;6:502-8
|How to cite this URL:|
Singh SS, Paul SK, Pal R, Thatkar PV. Acute coronary syndrome-related mortality audit in a teaching hospital at Port Blair, India. J Family Med Prim Care [serial online] 2017 [cited 2021 May 17];6:502-8. Available from: https://www.jfmpc.com/text.asp?2017/6/3/502/222033
| Introduction|| |
Acute coronary syndrome (ACS) is important global causes of death and also the major cause of morbidity and mortality in India. In Urban India, coronary heart disease (CHD) prevalence in adult has increased considerably and occurred at a much younger age as compared to North America and Western Europe., CHD global fatality was estimated to be 17.5 million/year, 31% of deaths - 75% in low- and middle-income countries; the prevalence of CHD in rural India was estimated to be 3%–4% and 8%–10% in urban areas., Thrombolytic therapy is a proven therapy for acute myocardial infarction (AMI) cases with ST elevation in electrocardiogram (ECG) that can be administered by any properly trained health-care provider, even in the prehospital setting. Among the health conditions in Andaman and Nicobar Islands, the cardiovascular diseases in general and AMI has been a perennial problem in Andaman and Nicobar Islands.
With this background, this study was performed by systematically recording the clinical profile of patients with ACS treated between April 2010 and March 2016 at GB Pant Hospital, Port Blair, in an attempt to identify various outcomes. To the horizon of our knowledge, we are the first to report on clinical spectrum, risk factors, and deaths in ACS cases in these islands.
| Methods|| |
This study was conducted on 491 patients with ACS admitted at the Intensive Care Unit of GB Pant Hospital, Port Blair, the only teaching institute of Andaman and Nicobar Islands from April 2010 to March 2016. During inpatient management, the cases were followed up from admission till discharge or death. The World Health Organization definition was followed for the diagnosis of AMI in this study. Initial 12 lead ECG was recorded on BPL Cardiart 408, immediately on admission and subsequently at 8 hourly intervals on the 1st day, thereafter as per need; also before and after the thrombolytic therapy.
During admission, high-risk consent was obtained from the patients after explaining the details of the clinical findings, reasons for admission, and probable management plan.
Other investigations were done as follows:
- Urine routine analysis (sugar, albumin, and microscopy)
- Blood routine (hemoglobin percent, total and differential leukocyte count, erythrocyte sedimentation rate)
- Random blood sugar (or fasting/postprandial blood sugar), blood urea, serum creatinine
- Lipid profile
- Echocardiography (two-dimensional) was done to confirm myocardial infarction
- Chest X-ray (if required)
- Serum electrolytes (if required).
All consecutive cases presented with symptoms suggestive of ACS.
Those cases with proven noncardiac chest pain and those discharged before completion of the treatment for any reason.
ST-elevated myocardial infarction (STEMI) was defined by characteristic symptoms of myocardial ischemia in association with persistent ECG ST elevation and consequent release of biomarkers of myocardial necrosis.
Non-ST-elevated myocardial infarction/unstable angina
Persons reported with symptoms suggestive of suspected myocardial infarction without persistent ST elevation in ECG.
AMI cases, which presented within 12 h of the appearance of symptoms with persistent ST elevation, were administered streptokinase/tenecteplase.
Absolute contraindications for thrombolysis in STEMI (a) prior intracranial hemorrhage, (b) known structural cerebral vascular lesion, (c) known malignant intracranial neoplasm, (d) ischemic stroke within 3 months, (e) suspected aortic dissection, (f) active bleeding or bleeding diathesis, (g) significant closed head trauma or facial trauma within 3 months, (h) severe uncontrolled hypertension (HTN), and (i) intracranial or intraspinal surgery within 2 months.
Relative contraindications (a) history of chronic, severe, poorly controlled HTN; (b) significant HTN on presentation >180/110 mmHg; (c) traumatic or prolonged (more than 10 min) cardiopulmonary resuscitation or major surgery <3 weeks previously; (d) history of prior ischemic stroke not within the last 3 months; (e) dementia; (f) recent (within 2–4 weeks) internal bleeding; (g) pregnancy; (h) noncompressible vascular punctures; (i) active peptic ulcer; and (j) current use of an anticoagulant that has produced an international normalized ratio >1.7 or a prothrombin time longer than 15 s.,
The study was approved by the Medical Superintendent, GB Pant Hospital, Port Blair. Ethical principles were adhered to while gathering the information with strict confidentiality.
Statistical analysis was performed using the softwareSPSS version 20 (SPSS IBM (PC + version 20.0)). Multivariate binary logistic regression was carried out to find a relation between the risk factors with the outcomes, considering the alpha level of error as 5%.
| Results|| |
Of the 491 cases, great majority 373 (75.99%) were STEMI, unstable angina 108 (21.99%), and non-STEMI 10 (1.98%). The mean age of 418 survived cases was 56.75 ± 10.47 while in 73 deaths, it was 58.01 ± 13.60. Majority (76.58%) of cases was males across all age groups; the male: female ratio was 3.3:1. An overall highest number were in the age group 51–60 (34.21%) followed by 41–50 (26.88%); notably only 27 (5.50%) were 40 years and below, elderly population (61 and above) were one in three (33.40%). Hindus were 72.51% tallying with the demography of Andaman and Nicobar Islands; 83.10% reported some form of physical activities and only 6.52% were vegetarian, 52.95% were diabetics, 47.45% hypertensives, 34.22% smokers, only 51 (10.39%) had a family history of myocardial infarction, and majority of the cases (59.06%) were from white collar profession (teacher, clerical, etc.) [Table 1].
|Table 1: Risk correlates of admitted cases suspected of myocardial infarction|
Click here to view
Out of all admitted cases, deaths was in 73 (14.87%); mortality probability among females was less (12.17%) compared to males (15.69%). Case fatality rates were the lowest in the age group 41–50 years (7. 58%) followed by 51–60 years (9.52%), similar among both genders. Of the fatal cases, 59 (80.82%) were males across all age groups. The highest proportional death rate was in 31–40 age group (30.43%) followed 61–70 (26.47%) and more than 70 years (19.35%) [Table 2].
Association between demographic, comorbidity, and lifestyle-related variables was tested using Chi-square test. ACS deaths were significantly associated with diabetes, HTN, smoking and family history, and not so with gender, religion, dietary habits, and physical activity [Table 3].
Backward multivariate binary logistic regression was applied, and it was noted that physical activities and vegetarian diet were not protective; addiction to smoking was significantly (P = 0.023) associated with death. Among comorbidities, diabetes was most significantly (P = 0.002) associated with death followed by HTN (P = 0.009). A family history of myocardial infarction was also a significant (P = 0.030) risk factor [Table 4].
|Table 4: Multivariate binary logistic regression of risk correlates of myocardial infarction deaths|
Click here to view
Thrombolytic was administered to 114 (23.65%) STEMI cases, out of which 84 (73.68%) survived, while 88.32% of nonrecipient also survived; odds ratio of survival with thrombolysis was 2.699 (95% confidence interval = 1.598–4.560, P < 0.0002) showing benefit to recipients.
| Discussion|| |
Of the 491 cases, STEMI were 75.99%. INTERHEART-South Asia noted that nearly half of AMI cases in Indians were STEMI ,, corroborating with CREATE registry.
In our study, the highest number of cases was among 51–60 years (34.21%). Mean age of survived cases was 56.75 ± 10.47 and among dead 58.01 ± 13.60; these findings were comparable to CREATE registry,, and two studies reported from Pakistan , and Chennai study . On the contrary studies on migrant Asian Indians showed higher prevalence of AMI at relatively younger ages., Research group from South India noted maximum patients in 51–60 years (31%), followed by 41–50 years (26%). Another South Indian study showed comparable age distribution. The mean age of ischemic heart disease (IHD) cases in Bengal was 52.8 years and increased with age; highest among 80 years or above (40.0%) and lowest in 40–49 year age group (5.4%).
Males were 76.58% with male: female ratio 3.3:1 in our series, whereas Pakistani studies reported 78% and 88.5% males., Kerala study reported 72.9% males and male: female ratio 2.68:1, though contrast was in Chennai study. Gujarat study reported 71.7% males among STEMI cases with the male: female ratio 3.6:1. South Indian study noted maximum AMI among males (82%) with the male: female ratio 4.5:1. In North Bengal study, higher prevalence of coronary artery disease (CAD) was noted among males. Male preponderance among STEMI cases in all age groups was observed in North India.
In our series, 52.95% had diabetes among AMI cases, which was supported by the global literature. Kerala study reported diabetes among 31.47% cases with STEMI with the hypothesis of positive relation. Other studies from India showed diabetes as an important determinant of CAD.,,,
In our series, 47.45% were hypertensive among AMI cases. Global researchers observed HTN as major risk factor for STEMI cases; with an exception in South Asian population. Indian studies noted significant association of CVD cases with HTN.,,,,, Studies reported higher numbers of females with STEMI, having HTN.
In our series, 34.22% reported tobacco smoking; International Research Groups noted smoking or smokeless tobacco as major risk factor for STEMI. Researchers linked cigarette smoking with an increased risk of CHD among diabetic women; quitting smoking declined this additional risk. In Kerala study, smoking was a risk factor among 52.55% of cases, Gujarat study 28.3%, South Indian study 76%, yet smoking found no association with CAD cases in Chennai study., In North Bengal study, the prevalence of IHD among smokers was significantly higher than in nonsmokers. Other published literature correlated smoking to be an important risk factor for CAD in Indian population.
In our series, only 6.52% were vegan. International Research Group reported that vegetarian diet reduced the risk of CAD, due to avoidance of meat. Different research groups perceived that vegetarian diet reduces the incidence of CAD and recommended restriction of dietary saturated fats. Research groups in India observed that low consumption of fruits and vegetables was important determinants of CVD ,, although North Bengal study could not find any such relationship. “The Seven Countries Study” believed that the force of a risk factor such as dietary saturated fat and antioxidant deficiency may vary among population groups. Rising incidence of ACS was related to Westernized food practices in India.
In our series, 83.09% reported regular physical activity. Since last six decades, International Research Groups observed the protective role of physical activities with the onset of the CVDs; active people had lower rates of CVD.,,, The Seven Countries Study indicated the potential protective effect of physical activity on CAD. Rising incidence of ACS in Indians has been related to lifestyle changes. Literature reported sedentary lifestyles as important determinants of cardiovascular diseases in India. It is also possible that the risk factors differed with lifestyle changes among migrants. However, no significant relation was found between physical activities and IHD in a population-based study from North Bengal, India.
In our series, 10.39% of the AMI cases reported having a family history. INTERHEART study indicated the importance of family history for CAD among young Indians. Researchers from India reported less (7%) family history of among AMI cases. The rising incidence of ACS in Indians may be related to familial hereditary factors acting upon modifiable risk factors, an important independent risk factor for CAD in younger cases.,,,
Thrombolytic therapy is indicated with evidence of STEMI within 12 h of the onset of symptoms, and the goal is a door-to-needle time of below 30 min to minimize the time to therapy. Although streptokinase/tenecteplase is available in our hospital free of cost to all the patients, yet 114 (23.65%) STEMI patients could be thrombolyzed for the remoteness of this area, yet a good number of STEMI cases arrived early with survival benefit to the recipient compared to other studies. Treatment in hospital with thrombolysis is more common in India than in other developing countries although injection streptokinase/tenecteplase to be administered under careful monitoring. In centers with a higher prevalence of primary angioplasty, an estimated 7.5% of AMIs are treated with angioplasty in India to avoid prohibitive costs. In Kerala study 68.97%, in Gujarat 79.7% of cases were thrombolyzed, higher than CREATE registry. A systematic review from India had shown that streptokinase is highly cost effective. Despite the availability of guidelines, there is a need to evaluate striking practice variations in different centers present in the use of thrombolytic therapies.
Death during stay at hospital
In our study, in-hospital mortality rate was 14.87% among admitted AMI cases; majority of deaths were in the age group 31–40 (30.43%) though survival probability was less among males; this was much higher than CREATE registry (5.6%). Kerala study reported 8.04% death among MI cases, where coexistent cardiovascular risk factors, namely diabetes mellitus, HTN, and smoking history did not reveal any statistically higher risk for death. CAD deaths change consequent to affluence and cultural changes due to migration. Our mortality data correlated with literature from Pakistan  and India (Gujarat) both reported 13.2%. Other studies also concurred high incidence of ACS among Indians, resulting in high mortality as compared to Global data.,,,,
Strength of the study
This study was undertaken for the first time in Andaman and Nicobar Islands in the only teaching hospital, and the inclusion of census population covered all the seasons to discern seasonal trends.
Limitations of the study
This was a single center study with our limited resources. By this endeavor, we have only managed to scratch the surface of the problem of AMI fatalities in our study.
Future directions of study
A national level prospective longitudinal registry is required to throw light on risk factors for various cardiovascular endpoints. However, the basic problem in the AMI management in Indian infrastructure is a lack of logistics for which we need to improve prehospital care.
| Conclusions|| |
We attempted to identify various factors involved in AMI cases to enable us to improve future care. There is a need for early detection of a risk factor to prevent the progression of ACS, creating awareness in the community regarding risk factors, symptoms and signs of AMI for early referral to definitive care units to prevent morbidity and mortality in the community. Urgent strategies are required to modify lifestyle by enhancing physical activities, meditation, yoga, and others may be synergistic in controlling mind-body interactions that are important in the preventive strategy to lessen pathogenesis of cardiovascular diseases.
We acknowledge Dr. M. K. Saha Medical Superintendent, GB Pant Hospital, for his sincere support to conduct our study.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Banerjee A. Coronary artery disease and its problems in management. J Indian Med Assoc 2001;99:474-5.
Gupta R. Burden of coronary heart disease in India. Indian Heart J 2005;57:632-8.
Gupta R. Coronary heart disease in India: Absolute numbers and economic burden. Rapid response to Ghaffar A, Reddy KS, Singhi M. Burden of non-communicable diseases in South Asia. BMJ 2004;328:807.
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, et al.
Third universal definition of myocardial infarction. Circulation 2012;126:2020-35.
O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr., Chung MK, de Lemos JA, et al.
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;127:e362-425.
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al.
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004;364:937-52.
Misiriya KJ, Sudhayakumar N, Khadar SA, George R, Jayaprakasht VL, Pappachan JM. The clinical spectrum of acute coronary syndromes: Experience from a major center in Kerala. J Assoc Physicians India 2009;57:377-83.
Gupta R. Recent trends in coronary heart disease epidemiology in India. Indian Heart J 2008;60 2 Suppl B: B4-18.
Xavier D, Pais P, Devereaux PJ, Xie C, Prabhakaran D, Reddy KS, et al.
Treatment and outcomes of acute coronary syndromes in India (CREATE): A prospective analysis of registry data. Lancet 2008;371:1435-42.
Hafeez S, Javed A, Kayani AM. Clinical profile of patients presenting with acute ST elevation myocardial infarction. J Pak Med Assoc 2010;60:190-3.
Siddiuqi AH, Kayani AM. Acute myocardial infarction-clinical profile of 1000 cases. Pak Heart J 2000;32:42-5.
Mohan V, Deepa R, Rani SS, Premalatha G; Chennai Urban Population Study (CUPS No.). Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: The Chennai Urban Population Study (CUPS No 5). J Am Coll Cardiol 2001;38:682-7.
Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, et al.
Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: The Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000;356:279-84.
Vaidya CV, Majmudar DK. A study of clinical profile of acute ST elevation myocardial infarction patients from GMERS medical college and hospital, Gandhinagar, Gujarat. Int J Adv Med 2014;1:113-6.
Seetharama N, Mahalingappa R, Ranjith Kumar GK, Veerappa V, Aravindh CL. Clinical profile of acute myocardial infarction patients: A study in a tertiary care centre. Int J Res Med Sci 2015;3:412-9.
Jose VJ, Gupta SN. Mortality and morbidity of acute ST segment elevation myocardial infarction in the current era. Indian Heart J 2004;56:210-4.
Mandal S, Saha JB, Mandal SC, Bhattacharya RN, Chakraborty M, Pal PP. Prevalence of ischemic heart disease among urban population of Siliguri, West Bengal. Indian J Community Med 2009;34:19-23.
] [Full text]
Holay MP, Janbandhu A, Javahirani A, Pandharipande MS, Suryawanshi SD. Clinical profile of acute myocardial infarction in elderly (prospective study). J Assoc Physicians India 2007;55:188-92.
Steg PG, Goldberg RJ, Gore JM, Fox KA, Eagle KA, Flather MD, et al.
Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 2002;90:358-63.
Al-Delaimy WK, Manson JE, Solomon CG, Kawachi I, Stampfer MJ, Willett WC, et al.
Smoking and risk of coronary heart disease among women with type 2 diabetes mellitus. Arch Intern Med 2002;162:273-9.
Mitra A, Pradhan R, Mukherjee S. Importance of heart-healthy diet. J Hum Ecol 2009;27:53-61.
Chang-Claude J, Hermann S, Eilber U, Steindorf K. Lifestyle determinants and mortality in German vegetarians and health-conscious persons: Results of a 21-year follow-up. Cancer Epidemiol Biomarkers Prev 2005;14:963-8.
Rastogi T, Reddy KS, Vaz M, Spiegelman D, Prabhakaran D, Willett WC, et al.
Diet and risk of ischemic heart disease in India. Am J Clin Nutr 2004;79:582-92.
De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al.
European guidelines on cardiovascular disease prevention in clinical practice: Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2003;10:S1-S10.
Physical Activity Guidelines Committee. Physical Activity Guidelines Advisory Committee Report. Washington, DC: Dept. of Health and Human Services; 2008.
Nocon M, Hiemann T, Müller-Riemenschneider F, Thalau F, Roll S, Willich SN. Association of physical activity with all-cause and cardiovascular mortality: A systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 2008;15:239-46.
Sofi F, Capalbo A, Cesari F, Abbate R, Gensini GF. Physical activity during leisure time and primary prevention of coronary heart disease: An updated meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil 2008;15:247-57.
Goel PK, Bharti BB, Pandey CM, Singh U, Tewari S, Kapoor A, et al.
A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease. Indian Heart J 2003;55:234-40.
Srivastava RK, Tiwari S, Singh P, Puri A, Chaudhary G, Ali W, et al
. Gender risk profile in acute myocardial infarction – A prospective study in Indian population. Int J Sci Res Publ 2014;4:1-3.
Grover G, Gadpayle AK, Dutta R. A study of cardiovascular risk factors in Delhi, India. J Commun Dis 2009;41:71-80.
Sharma M, Ganguly NK. Premature coronary artery disease in Indians and its associated risk factors. Vasc Health Risk Manag 2005;1:217-25.
Abdallah MH, Arnaout S, Karrowni W, Dakik HA. The management of acute myocardial infarction in developing countries. Int J Cardiol 2006;111:189-94.
Budaj A, Brieger D, Steg PG, Goodman SG, Dabbous OH, Fox KA, et al.
Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: Insights from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2003;146:999-1006.
Monteiro P; Portuguese Registry on Acute Coronary Syndromes. Impact of early coronary artery bypass graft in an unselected acute coronary syndrome patient population. Circulation 2006;114 1 Suppl: I467-72.
Prabhakaran D, Yusuf S, Mehta S, Pogue J, Avezum A, Budaj A, et al.
Two-year outcomes in patients admitted with non-ST elevation acute coronary syndrome: Results of the OASIS registry 1 and 2. Indian Heart J 2005;57:217-25.
Tan AT, Emmanuel SC, Tan BY, Teo WS, Chua TS, Tan BH. Myocardial infarction in Singapore: A nationwide 10-year study of multiethnic differences in incidence and mortality. Ann Acad Med Singapore 2002;31:479-86.
Mak KH, Chia KS, Kark JD, Chua T, Tan C, Foong BH, et al.
Ethnic differences in acute myocardial infarction in Singapore. Eur Heart J 2003;24:151-60.
Lloyd-Jones DM, Leip EP, Larson MG, D'Agostino RB, Beiser A, Wilson PW, et al.
Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006;113:791-8.
[Table 1], [Table 2], [Table 3], [Table 4]
|This article has been cited by|
||Treatment outcome of acute coronary syndrome patients admitted to Ayder Comprehensive Specialized Hospital, Mekelle, Ethiopia; A retrospective cross-sectional study
| ||Desilu Mahari Desta,Teshome Nedi,Abraha Hailu,Tesfay Mehari Atey,Afewerki Gebremeskel Tsadik,Solomon Weldegebriel Asgedom,Gebremicheal Gebereslassie Kasahun,Eskinder Ayalew,Chiara Lazzeri |
| ||PLOS ONE. 2020; 15(2): e0228953 |
|[Pubmed] | [DOI]|
||Non-traumatic chest pain in patients presenting to an urban emergency Department in sub Saharan Africa: a prospective cohort study in Tanzania
| ||Amour S. Mohamed,Hendry R. Sawe,Biita Muhanuzi,Nafsa R. Marombwa,Kilalo Mjema,Ellen J. Weber |
| ||BMC Cardiovascular Disorders. 2019; 19(1) |
|[Pubmed] | [DOI]|